Travel Grant to Switzerland – Swiss Nordic Bio, 1 October 2026

Important results from the project

The project´s objective was well met. Through participation at Swiss Nordic Bio, Cordicity was given the opportunity to present the company and its technology to an international audience and conduct targeted meetings with investors and industry players. The project resulted in new qualified contacts and continued dialogues around funding, strategic partnerships and international collaborations. This strengthens Cordicity´s continued internationalization and commercialization.

Expected long term effects

The project is expected to strengthen Cordicity´s international position and create long-term conditions for funding, strategic partnerships and market access. The networks and relationships established can contribute to new investor and industry collaborations and thereby accelerate the company´s commercialization and introduction of Swedish medical technology innovation in international markets.

Approach and implementation

The project was implemented according to plan. Pitch, investor materials and meetings were prepared and adapted beforehand. On site, Cordicity presented the company in the selected pitch session, conducted pre-booked 1-to-1 meetings with international investors and participated in the conference´s networking activities. The setup proved to be well adapted to the project´s objective and relevant contacts have been followed up after the conference.